Blood-brain barrier transport machineries and targeted therapy of brain diseases
Tóm tắt
Từ khóa
Tài liệu tham khảo
Begley DJ, 2004, ABC transporters and the blood-brain barrier, Curr Pharm Des, 10, 1295, 10.2174/1381612043384844
Wood MJ, 2011, Exosomes and the blood-brain barrier: implications for neurological diseases, Ther Deliv, 2, 1095, 10.4155/tde.11.83
O’Loughlin AJ, 2012, Exosomes and the emerging field of exosome-based gene therapy, Curr Gene Ther, 12, 262, 10.2174/156652312802083594
Gumbleton M, 2001, Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier, J Pharm Sci, 90, 1681, 10.1002/jps.1119
Barar J, 2010, Barrier functionality and transport machineries of human ECV304 cells, Med Sci Monit, 16, 52
Omidi Y, 2003, Evaluation of the immortalised mouse brain capillary endothelial cell line, bEnd3, as an in vitro blood-brain barrier model for drug uptake and transport studies, Brain Res, 990, 95, 10.1016/S0006-8993(03)03443-7
Rapoport SI, 1978, Osmotic opening of the blood-brain barrier, Ciba Found Symp, 237
Easton AS, 2002, Bradykinin increases permeability by calcium and 5-lipoxygenase in the ECV304/C6 cell culture model of the blood-brain barrier, Brain Res, 953, 157, 10.1016/S0006-8993(02)03281-X
Sanovich E, 1995, Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7, Brain Res, 705, 125, 10.1016/0006-8993(95)01143-9
Abbott NJ, 2000, Inflammatory mediators and modulation of blood-brain barrier permeability, Cell Mol Neurobiol, 20, 131, 10.1023/A:1007074420772
Ordovas JM, 2000, ABC1: the gene for Tangier disease and beyond, Nutr Rev, 58, 76, 10.1111/j.1753-4887.2000.tb01843.x
Nicolazzo JA, 2009, Drug transport across the blood-brain barrier and the impact of breast cancer resistance protein (ABCG2), Curr Top Med Chem, 9, 130, 10.2174/156802609787521580
Pardridge WM, 1990, Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier Studies with quantitative western blotting and in situ hybridization, J Biol Chem, 265, 18035, 10.1016/S0021-9258(18)38267-X
Miller LP, 1986, Regional kinetic constants for blood-brain barrier pyruvic acid transport in conscious rats by the monocarboxylic acid carrier, J Neurochem, 46, 1412, 10.1111/j.1471-4159.1986.tb01756.x
Oldendorf WH, 1973, Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids, Am J Physiol, 224, 1450, 10.1152/ajplegacy.1973.224.6.1450
Conn AR, 1983, Characterization of alpha-keto acid transport across blood-brain barrier in rats, Am J Physiol, 245, E253
Kido Y, 2001, Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier, J Pharm Pharmacol, 53, 497, 10.1211/0022357011775794
Kageyama T, 2000, The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier, Brain Res, 879, 115, 10.1016/S0006-8993(00)02758-X
O’Kane RL, 1999, Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier A mechanism for glutamate removal, J Biol Chem, 274, 31891, 10.1074/jbc.274.45.31891
Benrabh H, 1996, Glutamate is transported across the rat blood-brain barrier by a sodium-independent system, Neurosci Lett, 210, 9, 10.1016/0304-3940(96)12635-5
Stoll J, 1993, Identification of the cationic amino acid transporter (System y+) of the rat blood-brain barrier, J Neurochem, 60, 1956, 10.1111/j.1471-4159.1993.tb13428.x
Benrabh H, 1995, Taurine transport at the blood-brain barrier: an in vivo brain perfusion study, Brain Res, 692, 57, 10.1016/0006-8993(95)00648-A
Tamai I, 1995, Na(+)- and Cl(-)-dependent transport of taurine at the blood-brain barrier, Biochem Pharmacol, 50, 1783, 10.1016/0006-2952(95)02046-2
Komura J, 1997, Brain-to-blood active transport of beta-alanine across the blood-brain barrier, FEBS Lett, 400, 131, 10.1016/S0014-5793(96)01366-X
Murakami H, 2000, Characteristics of choline transport across the blood-brain barrier in mice: correlation with in vitro data, Pharm Res, 17, 1526, 10.1023/A:1007613326759
Kang YS, 1990, In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier, J Pharmacobiodyn, 13, 353, 10.1248/bpb1978.13.353
Karlsson C, 1984, Choline transport through the blood-retinal and the blood-brain barrier in vivo, Acta Ophthalmol (Copenh), 62, 763, 10.1111/j.1755-3768.1984.tb05804.x
Masereeuw R, 1994, In vitro and in vivo transport of zidovudine (AZT) across the blood-brain barrier and the effect of transport inhibitors, Pharm Res, 11, 324, 10.1023/A:1018932213953
Tsuji A, 1999, Carrier-mediated or specialized transport of drugs across the blood-brain barrier, Adv Drug Deliv Rev, 36, 277, 10.1016/S0169-409X(98)00084-2
Adkison KD, 1996, Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter, J Pharmacol Exp Ther, 276, 1189
Dick AP, 1984, Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity, Proc Natl Acad Sci U S A, 81, 7233, 10.1073/pnas.81.22.7233
Cornford EM, 2000, Acute upregulation of blood-brain barrier glucose transporter activity in seizures, Am J Physiol Heart Circ Physiol, 279, H1346, 10.1152/ajpheart.2000.279.3.H1346
Verrey F, 2000, Glycoprotein-associated amino acid exchangers: broadening the range of transport specificity, Pflugers Arch, 440, 503, 10.1007/s004240000274
Wagner CA, 2000, The heterodimeric amino acid transporter 4F2hc/LAT1 is associated in Xenopus oocytes with a non-selective cation channel that is regulated by the serine/threonine kinase sgk-1, J Physiol, 526 Pt 1, 35, 10.1111/j.1469-7793.2000.00035.x
Broer A, 2001, Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains, Biochem J, 355, 725, 10.1042/bj3550725
Wagner CA, 2001, Function and structure of heterodimeric amino acid transporters, Am J Physiol Cell Physiol, 281, C1077, 10.1152/ajpcell.2001.281.4.C1077
Hosoya K, 2002, Enhancement of L-cystine transport activity and its relation to xCT gene induction at the blood-brain barrier by diethyl maleate treatment, J Pharmacol Exp Ther, 302, 225, 10.1124/jpet.302.1.225
Markazi S, 2016, A Novel Mutation in SLC3A1 Gene in Patients With Cystinuria, Iran J Kidney Dis, 10, 44
Matsuo H, 2000, Expression of a system L neutral amino acid transporter at the blood-brain barrier, Neuroreport, 11, 3507, 10.1097/00001756-200011090-00021
Nii T, 2001, Molecular events involved in up-regulating human Na+-independent neutral amino acid transporter LAT1 during T-cell activation, Biochem J, 358, 693, 10.1042/bj3580693
Kim DK, 2002, Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells, Biochim Biophys Acta, 1565, 112, 10.1016/S0005-2736(02)00516-3
Kanai Y, 2003, Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity, J Toxicol Sci, 28, 1, 10.2131/jts.28.1
Boado RJ, 1999, Selective expression of the large neutral amino acid transporter at the blood-brain barrier, Proc Natl Acad Sci U S A, 96, 12079, 10.1073/pnas.96.21.12079
Meier C, 2002, Activation of system L heterodimeric amino acid exchangers by intracellular substrates, EMBO J, 21, 580, 10.1093/emboj/21.4.580
Yanagida O, 2001, Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines, Biochim Biophys Acta, 1514, 291, 10.1016/S0005-2736(01)00384-4
Segawa H, 1999, Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity, J Biol Chem, 274, 19745, 10.1074/jbc.274.28.19745
Rossier G, 1999, LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine, J Biol Chem, 274, 34948, 10.1074/jbc.274.49.34948
Kaira K, 2011, Relationship between LAT1 expression and response to platinum-based chemotherapy in non-small cell lung cancer patients with postoperative recurrence, Anticancer Res, 31, 3775
Kaira K, 2015, Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in patients with pancreatic cancer, Am J Transl Res, 7, 356
Broer S, 2001, Transfer of glutamine between astrocytes and neurons, J Neurochem, 77, 705, 10.1046/j.1471-4159.2001.00322.x
Omidi Y, Gumbleton M. Biological membranes and barriers. Biomaterials for Delivery and Targeting of Proteins Nucleic Acids, Mahato, RI (Ed): CRC Press, New York; 2005. p. 232-74.
Boleti H, 1997, Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells, Neuropharmacology, 36, 1167, 10.1016/S0028-3908(97)00136-6
Damaraju S, 2005, Identification and functional characterization of variants in human concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from single nucleotide polymorphisms in coding regions of the hCNT3 gene, Pharmacogenet Genomics, 15, 173, 10.1097/01213011-200503000-00006
Balzarini J, 1998, Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection, J Acquir Immune Defic Syndr Hum Retrovirol, 17, 296, 10.1097/00042560-199804010-00002
Schinkel AH, 1999, P-Glycoprotein, a gatekeeper in the blood-brain barrier, Adv Drug Deliv Rev, 36, 179, 10.1016/S0169-409X(98)00085-4
Ganapathy V, 1991, Proton-coupled solute transport in the animal cell plasma membrane, Curr Opin Cell Biol, 3, 695, 10.1016/0955-0674(91)90043-X
Zhou X, 2000, Characterization of an oligopeptide transporter in renal lysosomes, Biochim Biophys Acta, 1466, 372, 10.1016/S0005-2736(00)00201-7
Momburg F, 1994, Peptide selection by MHC-encoded TAP transporters, Curr Opin Immunol, 6, 32, 10.1016/0952-7915(94)90030-2
Roelse J, 1994, Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling, J Exp Med, 180, 1591, 10.1084/jem.180.5.1591
Tsuji A, 1999, Tissue selective drug delivery utilizing carrier-mediated transport systems, J Control Release, 62, 239, 10.1016/S0168-3659(99)00043-7
Zhang Y, 2013, Prodrug design targeting intestinal PepT1 for improved oral absorption: design and performance, Curr Drug Metab, 14, 675, 10.2174/1389200211314060004
Omidi Y, 2005, Toxicogenomics of cationic lipid-based vectors for gene therapy: impact of microarray technology, Curr Drug Deliv, 2, 429, 10.2174/156720105774370249
Nomani A, 2010, Physicochemical and biological properties of self-assembled antisense/poly(amidoamine) dendrimer nanoparticles: the effect of dendrimer generation and charge ratio, Int J Nanomedicine, 5, 359
Schlachetzki F, 2002, Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier, J Neurochem, 81, 203, 10.1046/j.1471-4159.2002.00840.x
Schnitzer JE, 1992, gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis, Am J Physiol, 262, H246
Vogel SM, 2001, Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein, Am J Physiol Lung Cell Mol Physiol, 281, L1512, 10.1152/ajplung.2001.281.6.L1512
Piper RC, 2001, Late endosomes: sorting and partitioning in multivesicular bodies, Traffic, 2, 612, 10.1034/j.1600-0854.2001.20904.x
Dice JF, 1992, Selective degradation of cytosolic proteins by lysosomes, Ann N Y Acad Sci, 674, 58, 10.1111/j.1749-6632.1992.tb27477.x
Dice JF, 1990, Targeting of cytosolic proteins to lysosomes for degradation, Crit Rev Ther Drug Carrier Syst, 7, 211
Razani B, 2002, Caveolae: from cell biology to animal physiology, Pharmacol Rev, 54, 431, 10.1124/pr.54.3.431
Gumbleton M, 2001, Caveolae-mediated membrane transport, Adv Drug Deliv Rev, 49, 217, 10.1016/S0169-409X(01)00137-5
Gumbleton M, 2003, Targeting caveolae for vesicular drug transport, J Control Release, 87, 139, 10.1016/S0168-3659(02)00358-9
DeGrella RF, 1982, Intracellular transport of cholesterol to the plasma membrane, J Biol Chem, 257, 14256, 10.1016/S0021-9258(19)45374-X
Kaplan MR, 1985, Transport of cholesterol from the endoplasmic reticulum to the plasma membrane, J Cell Biol, 101, 446, 10.1083/jcb.101.2.446
Popova NV, 2013, Clathrin-mediated endocytosis and adaptor proteins, Acta Naturae, 5, 62, 10.32607/20758251-2013-5-3-62-73